HLS Therapeutics Inc
F:74D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
HLS Therapeutics Inc
F:74D
|
CA |
|
J
|
Johnson & Johnson
F:JNJ
|
US |
|
A
|
Avicanna Inc
F:0NN
|
CA |
|
Biogaia AB
OTC:BGLAF
|
SE |
|
S
|
Singapore Airlines Ltd
OTC:SINGF
|
SG |
|
N
|
Nikon Corp
XMUN:NKN
|
JP |
|
C
|
Commerzbank AG
F:ZZMS
|
DE |
|
Mitsubishi HC Capital Inc
F:5B4
|
JP |
|
P
|
Perusahaan Gas Negara Tbk PT
XMUN:PGB1
|
ID |
|
C
|
China Mobile Ltd
XMUN:CTM
|
CN |
Dividends
Dividend Yield
HLS Therapeutics Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
HLS Therapeutics Inc
74D have decreased by 0%.
Payout Ratio
HLS Therapeutics Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 74D is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
74D Price
HLS Therapeutics Inc
| Average Annual Return | -28.34% |
| Standard Deviation of Annual Returns | 24.45% |
| Max Drawdown | -85% |
| Market Capitalization | 147.3m EUR |
| Shares Outstanding | 31 814 500 |
| Percentage of Shares Shorted |
N/A
|
